X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.040
+0.010 (0.25%)
At close: Aug 21, 2026, 4:00 PM EDT
4.127
+0.087 (2.15%)
After-hours: Aug 21, 2026, 7:30 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $400.55 million as of August 21, 2026. Its market cap has increased by 537.24% in one year.
Market Cap
400.55M
Enterprise Value
269.81M
1-Year Change
537.24%
Ranking
Category
Stock Price
$4.04
ChartMarket Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $400.55M, an increase of 293.57%. That is a compound annual growth rate of 20.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 400.55M | 14.53% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 419.85M |
| vTv Therapeutics | 413.19M |
| Vogenx | 410.85M |
| Lexeo Therapeutics | 400.37M |
| Fennec Pharmaceuticals | 395.91M |
| Enanta Pharmaceuticals | 392.32M |
| Rocket Pharmaceuticals | 385.31M |
| Arcturus Therapeutics Holdings | 382.29M |